What is benign prostatic hyperplasia (BPH) with calcification?

Prostate-related disorders predominantly affect male patients; among them, a subset of men develop benign prostatic hyperplasia (BPH) accompanied by calcification. So, what exactly is “benign prostatic hyperplasia with calcification”?

What Is Benign Prostatic Hyperplasia with Calcification?

Benign prostatic hyperplasia with calcification is a very common noncancerous condition in men that can cause urinary obstruction or difficulty urinating. It is sometimes detected incidentally on ultrasound examination. Calcifications may also occur in healthy individuals due to calcium salt deposition; these are frequently associated with BPH coexisting with chronic prostatitis. If, in addition to urinary difficulties, the patient experiences other symptoms—such as discomfort (e.g., pain, aching, or heaviness) in the lower abdomen, perineum, or lumbosacral region (i.e., around the anus), or even sexual dysfunction—this may indicate BPH complicated by prostatitis. In such cases, both conditions must be treated concurrently: managing the BPH while simultaneously addressing the prostatitis, thereby optimizing therapeutic outcomes and improving the patient’s quality of life.

Most cases of chronic prostatic hyperplasia are associated with calcification. Prostatic calcifications primarily occur at the interface between the central and peripheral zones of the prostate. Importantly, they neither impair urinary function nor carry malignant potential. Thus, calcifications are clinically benign and pose no harm to the patient. The primary clinical concern—and the main therapeutic target—is prostate enlargement itself, i.e., benign prostatic hyperplasia.

Pharmacologic treatment options include alpha-adrenergic blockers—such as terazosin and alfuzosin—which effectively improve urinary flow and rapidly alleviate symptoms, thereby enhancing the patient’s quality of life. We hope this explanation has been helpful!